Steven Mintz, Director at Serina Therapeutics, Inc. (SER), bought 6,000 shares at $6.47 ($39K) on 2024-09-12, disclosed to the SEC on 2024-09-16.
Open-market purchase of $39k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| SER | BUY | 2024-05-23 | $121K | — | Filing → |